Novartis (France)
In research, Novartis (France) stands highest in Medicine (#8,468 of 17,978 worldwide) and Health Sciences (#11,232 of 20,462 worldwide), over all time.
- World rank, all time
- #22,897 of 42,892
- Rank in France
- #1,394 of 2,321
- Research works
- 430 ▲ 8% vs 2013–17
- Citations
- 8.2k 19.1 per fractional work
- Top-10% rate
- 5.0% record average 16.5%
- Open access
- 25% world 28%
What is Novartis (France) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #8,468 of 17,978 | 15.2% | 264 | |
| Health SciencesDomain | #11,232 of 20,462 | 14.6% | 283 |
Each strip is that field’s whole ranked pool, with the notch where Novartis (France) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.0×. Every wedge is a field page.
- Immunology and Microbiology 5.0×
- Pharmacology, Toxicology and Pharmaceutics 4.9×
- Medicine 3.6×
- Chemistry 2.1×
- Health Professions 1.7×
- Economics, Econometrics and Finance 1.4×
- Biochemistry, Genetics and Molecular Biology 1.0×
- Neuroscience 0.5×
- Computer Science 0.2×
- Decision Sciences 0.2×
- Mathematics 0.2×
- Physics and Astronomy 0.2×
- Agricultural and Biological Sciences 0.1×
- Nursing 0.1×
- Business, Management and Accounting 0.1×
- Materials Science 0.1×
- Environmental Science 0.1×
- Engineering 0.1×
- Arts and Humanities 0.1×
- Psychology 0.1×
- Social Sciences 0.0×
Who are the top researchers at Novartis (France)?
Ranked on the composite score, S. Dejager, Vincent Gros and Gereon Nelles lead among researchers whose main affiliation is Novartis (France).
- 1 S. Dejager France · #548,124 worldwide 56 citations · 26 works
- 2 Vincent Gros France · #574,708 worldwide 8 citations · 29 works
- 3 Gereon Nelles France · #951,567 worldwide 28 citations · 17 works
- 4 I. Bourdeix France · #1,295,354 worldwide 0 citations · 16 works
- 5 Stéphane Quéré France · #1,528,693 worldwide 2 citations · 21 works
Which keywords describe research at Novartis (France)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Cognitive Impairment, Clinical Trials, Diagnostic Criteria, Multiple Sclerosis, Neuromyelitis Optica, Autoantibodies and Prognostic Factors.
- PET Imaging
- Immunology
- Cardiovascular Risk
- Asthma
- Headache Disorders
- Coronary Artery Disease
- Calcitonin Gene-Related Peptide
- Cytokines
- Migraine
- Immunotherapy
- Chemotherapy
- Atherosclerosis
- Neurological Disorders
- Cardiovascular Disease Prevention
- Quality of Life
- Autoantibodies
- Treatment
- Multiple Sclerosis
- Clinical Trials
- Epidemiology
- Inflammation
- Cognitive Impairment
- Diagnostic Criteria
- Neuromyelitis Optica
- Cardiovascular Disease
- Prognostic Factors
- Mutation
- Genetic Variants
- Targeted Therapy
- BCR-ABL
- Imatinib
- Rituximab
- Obesity
- Therapeutic Targets
- Chronic Lymphocytic Leukemia
- Genomic Aberrations
- Synthesis
- C-Reactive Protein
- Clinical Guidelines
- Medicinal Chemistry
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation5▲ 5.0×22 topics
- Epidemiology4▲ 2.1×29 topics
- Cognitive Impairment3▲ 28×5 topics
- Clinical Trials3▲ 10×10 topics
- Diagnostic Criteria3▲ 31×5 topics
- Multiple Sclerosis3▲ 172×1 topic
- Neuromyelitis Optica3▲ 172×1 topic
- Treatment2▲ 4.4×14 topics
- Cardiovascular Disease2▲ 4.6×10 topics
- Autoantibodies2▲ 21×7 topics
- Prognostic Factors2▲ 11×7 topics
- Quality of Life2▲ 2.9×7 topics
- Mutation2▲ 22×3 topics
- Cardiovascular Disease Prevention2▲ 40×2 topics
- Genetic Variants2▲ 20×4 topics
- Neurological Disorders2▲ 6.4×5 topics
- Targeted Therapy2▲ 16×4 topics
- Atherosclerosis2▲ 12×5 topics
- BCR-ABL2▲ 123×1 topic
- Chemotherapy2▲ 4.7×9 topics
- Imatinib2▲ 123×1 topic
- Immunotherapy2▲ 4.7×12 topics
- Rituximab2▲ 23×3 topics
- Migraine1▲ 76×2 topics
- Obesity1▲ 4.1×6 topics
- Cytokines1▲ 10×3 topics
- Therapeutic Targets1▲ 19×2 topics
- Calcitonin Gene-Related Peptide1▲ 66×1 topic
- Chronic Lymphocytic Leukemia1▲ 60×1 topic
- Coronary Artery Disease1▲ 23×2 topics
- Genomic Aberrations1▲ 60×1 topic
- Headache Disorders1▲ 114×1 topic
- Synthesis1▲ 7.0×5 topics
- Asthma1▲ 24×2 topics
- C-Reactive Protein1▲ 31×2 topics
- Cardiovascular Risk1▲ 8.1×4 topics
- Clinical Guidelines1▲ 8.5×5 topics
- Immunology1▲ 22×2 topics
- Medicinal Chemistry1▲ 8.5×6 topics
- PET Imaging1▲ 13×5 topics
Which research topics does Novartis (France) publish most on?
By volume in 2022–2025: Multiple Sclerosis Research Studies, Chronic Myeloid Leukemia Treatments, Migraine and Headache Studies and Chronic Lymphocytic Leukemia Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 3 works
- 2 Chronic Myeloid Leukemia Treatments Hematology 2 works
- 3 Migraine and Headache Studies Psychiatry and Mental health 1 works
- 4 Chronic Lymphocytic Leukemia Research Genetics 1 works
- 5 Asthma and respiratory diseases Physiology 1 works
- 6 Lipoproteins and Cardiovascular Health Surgery 1 works
- 7 Cardiovascular Disease and Adiposity Cardiology and Cardiovascular Medicine 1 works
- 8 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 9 Spondyloarthritis Studies and Treatments Rheumatology 1 works
- 10 Rheumatoid Arthritis Research and Therapies Rheumatology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Novartis (France)'s research output changed?
Output in 2018–2022 was 8% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Rueil-Malmaison
- IFP Énergies nouvelles
- Schneider Electric (France)
- Beicip Franlab (France)
- French Norwegian Foundation
- Vinci (France)
- Bristol-Myers Squibb (France)
- Geostock (France)
- Alcon (France)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.